---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-117768"
form_type: "8-K"
ticker: "CYDY"
cik: "0001175680"
company_name: "CytoDyn Inc."
filed_at: "2022-04-25T23:59:59+00:00"
generated_at: "2026-06-26T04:57:58.443483+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# CytoDyn reorganizes management: Ray remains CTO, Recknor no longer executive officer

## Summary
- Nitya G. Ray, Ph.D., no longer COO; continues as Chief Technology Officer.
- Christopher P. Recknor, M.D., named Senior Director of R&D, ceases to be executive officer.
- Board approved reorganization on April 19, 2022; effective immediately.

## SEC filing metadata
- accession: 0001193125-22-117768
- form_type: 8-K
- ticker: CYDY
- cik: 0001175680
- company_name: CytoDyn Inc.
- filed_at: 2022-04-25T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1175680/000119312522117768/0001193125-22-117768-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1175680/000119312522117768/d341269d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-117768
- JSON: https://secwatch.observer/filing/0001193125-22-117768.json
- Plain text: https://secwatch.observer/filing/0001193125-22-117768.txt

## Key facts
- Executive change
  Nitya G. Ray changed role as Chief Operating Officer at CytoDyn Inc..
  - Action: will no longer serve as Chief Operating Officer
  - Role: Chief Operating Officer
  source text: Nitya G. Ray, Ph.D., will continue in his role as Chief Technology Officer, but will no longer serve as Chief Operating Officer.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1175680/000119312522117768/0001193125-22-117768-index.htm
- Executive change
  Christopher P. Recknor changed role as Senior Director of Research and Development at CytoDyn Inc..
  - Action: will serve as Senior Director of Research and Development, but will no longer be an executive officer
  - Role: Senior Director of Research and Development
  source text: Christopher P. Recknor, M.D., will serve as Senior Director of Research and Development, but will no longer be an executive officer of the Company as defined in the rules of the Securities and Exchange Commission.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1175680/000119312522117768/0001193125-22-117768-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.